Molecular profiling of platinum resistant ovarian cancer: use of the model in clinical practice

Int J Cancer. 2006 Sep 15;119(6):1511; author reply 1512. doi: 10.1002/ijc.21985.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cisplatin / therapeutic use*
  • Drug Resistance, Neoplasm*
  • Female
  • Gene Expression Profiling*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism
  • Ovarian Neoplasms* / drug therapy
  • Ovarian Neoplasms* / genetics
  • Ovarian Neoplasms* / pathology
  • Prognosis

Substances

  • Antineoplastic Agents
  • Neoplasm Proteins
  • Cisplatin